Regulatory Intelligence

Global Antibiotic
Regulatory Landscape

Navigate GMP certifications, regulatory approvals, and compliance requirements for antibiotic API manufacturers and traders across every major market.

Regulatory Bodies by Region

Key agencies that govern antibiotic API manufacturing and import approvals

US FDA

United States

US-FDA

Drug Safety & Efficacy

The Food and Drug Administration regulates pharmaceutical manufacturing under 21 CFR Parts 210 & 211. cGMP compliance is mandatory for all drug manufacturers exporting to the US market.

EMA / EU-GMP

European Union

EU-GMP

European GMP Standards

The European Medicines Agency enforces EU-GMP guidelines. All API manufacturers exporting to EU must hold a valid EU-GMP certificate or be audited by an EU competent authority.

WHO Prequalification

Global

WHO-GMP

International Quality Standards

WHO Prequalification (PQ) is essential for supply to UN agencies, GAVI, and many low/middle income country procurement programmes. Covers quality, safety, and efficacy.

CDSCO

India

CDSCO

Indian Drug Regulation

The Central Drugs Standard Control Organisation is India's national regulatory authority. Schedule M compliance (GMP) is mandatory for all pharmaceutical manufacturers in India.

PMDA

Japan

PMDA

Japanese GMP

The Pharmaceuticals and Medical Devices Agency regulates drugs in Japan. Foreign API manufacturers must obtain PMDA approval and comply with Japanese GMP standards for market access.

TGA

Australia

TGA

Therapeutic Goods

The Therapeutic Goods Administration is Australia's regulator. API manufacturers must be listed on the Australian Register of Therapeutic Goods and pass TGA GMP audits.

ANVISA

Brazil

ANVISA

Brazilian Health Regulation

Agência Nacional de Vigilância Sanitária regulates health products in Brazil. Foreign API manufacturers must hold ANVISA GMP certification to supply the Brazilian market.

Health Canada

Canada

Health-CA

Canadian Drug Regulations

Health Canada oversees the Food and Drugs Act and associated regulations. Division 2 GMP requirements apply to all pharmaceutical manufacturers supplying the Canadian market.

MHRA

United Kingdom

MHRA

UK GMP Post-Brexit

The Medicines and Healthcare products Regulatory Agency is the UK regulator post-Brexit. UK-GMP compliance is required; mutual recognition agreements with EU are evolving.

Key Regulatory Standards

International GMP frameworks and quality standards for pharmaceutical manufacturers

ICH Q7

Good Manufacturing Practice for Active Pharmaceutical Ingredients

The ICH Q7 guideline provides harmonized GMP requirements for API manufacture, adopted by US FDA, EMA, and most major regulatory agencies worldwide.

WHO GMP (TRS 986)

WHO Technical Report Series 986

The core WHO GMP guidelines for pharmaceutical products. Frequently referenced by national regulators in developing countries and UN procurement.

ISO 15378

Primary Packaging Materials for Medicinal Products

ISO 15378 specifies GMP requirements for primary packaging materials used in pharmaceutical products, important for finished-form exporters.

ICH Q10

Pharmaceutical Quality System

Describes a comprehensive model for an effective pharmaceutical quality system that can be implemented throughout different stages of a product's lifecycle.

SCHEDULE M (Revised)

Indian GMP Standard — CDSCO

India's revised Schedule M under the Drugs and Cosmetics Act brings Indian GMP closer to ICH Q7 standards. Mandatory for all Indian API exporters from 2024.

PIC/S PE 009

Pharmaceutical Inspection Co-operation Scheme

PIC/S is an international co-operation covering 53 national authorities. PIC/S membership assures equivalent GMP standards across member countries.

Typical Certification Journey

Steps for an Indian API manufacturer to achieve multi-market regulatory status

01

Schedule M (India)

Baseline Indian GMP compliance — mandatory domestic requirement.

02

WHO-GMP

WHO Prequalification opens doors to UN procurement and global emerging markets.

03

EU-GMP / EUGMP

Audit by EU competent authority enables supply to all 27 EU member states.

04

US FDA Approval

Drug Master File (DMF) and ANDA/NDA filing for US market access.

Need Regulatory Guidance?

Our team can help you understand certification requirements for your target markets and connect you with verified regulatory consultants.